CHOC has earned a spot among Becker’s Hospital Review’s list of 36 hospitals and health systems with great diabetes and endocrinology programs.
According to the publication, selected hospitals and health systems offer services that support patients’ endocrine systems, and provide diagnoses, education, medication, cutting-edge technology and clinical research to improve the lives of patients experiencing endocrine disorders like diabetes, thyroid diseases, metabolic disorders and more.
CHOC’s endocrinology program is consistently ranked among the top 30 of Best Children’s Hospitals by U.S. News & World Report. The team of board-certified endocrinologists and specialists provides diagnostic evaluations and the latest minimally invasive, leading-edge treatments for newborns, adolescents and young adults.
Annually, the diabetes program diagnoses and treats over 3,000 Type 1 diabetes patients and 800 Type 2 diabetes patients, utilizing digital retinal imaging, point-of-care urine microalbumin and point-of-care lipid screenings. In collaboration with other subspecialties, the program also supports patients through the Endocrine Effects of Cancer Survivorship program, thyroid cancer program and cystic fibrosis-related diabetes program.
Pediatric endocrinologists also help support families by developing an individualized approach to early diagnosis and complications management associated with Prader-Willi Syndrome, a genetic disorder that affects growth, metabolism, appetite, behavior and learning. Part of an ongoing dedication to equity and access to care, CHOC partners with organizations to offer low- to no-cost genetic testing.
